Evidence map›Paper›PMID 24085645›Full record

ArticleInflammation2014

Protective effect of p-cymene on lipopolysaccharide-induced acute lung injury in mice.

Lvyi Chen, Lei Zhao, Chunfeng Zhang, Zhou Lan

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 53 citations in OpenAlex.

  1. The effects of carvacrol and p-cymene on AβCNS neuroscience & therapeutics · 2024
    Article
  2. Review
  3. Article
  4. Molecules (Basel, Switzerland) · 2022
    Article
  5. Article
  6. Review
  7. Article
  8. Effects ofMolecules (Basel, Switzerland) · 2020
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Laboratory animal research · 2017
    Article
  14. Review
  15. Terpenes from Forests and Human Health.Toxicological research · 2017
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Lvyi ChenCollege of Pharmacy, South-Central University for Nationalities, Wuhan, 430074, People's Republic of China.
Lei Zhao
Chunfeng Zhang
Zhou Lan
China Pharmaceutical University · CNGansu University of Traditional Chinese Medicine · CNHubei University of Chinese Medicine · CNSouth Central University for Nationalities · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the previous study, the anti-inflammatory effect of p-cymene had been found. In this study, we investigated anti-inflammatory effects of p-cymene on acute lung injury using lipopolysaccharide (LPS)-induced acute lung injury (ALI) mouse model. The cell counting in the bronchoalveolar lavage fluid (BALF) was measured. The animal lung edema degree was evaluated by wet/dry weight (W/D) ratio. The superoxidase dismutase (SOD) activity and myeloperoxidase (MPO) activity was assayed by SOD and MPO kits, respectively. The levels of inflammatory mediators including tumor necrosis factor alpha (TNF-α), IL-1β, and IL-6 were assayed by enzyme-linked immunosorbent assay method. The pathological changes of the lung tissues were observed by hematoxylin and eosin staining. The inflammatory signal pathway-related protein levels of NF-κB were measured using Western blotting. The data showed that treatment with the p-cymene markedly attenuated inflammatory cell numbers in the BALF, decreased NF-κB protein level in the lungs, improved SOD activity, and inhibited MPO activity. Histological studies demonstrated that p-cymene substantially inhibited LPS-induced neutrophils in the lung tissue compared with the model group. The results indicated that p-cymene had a protective effect on LPS-induced ALI in mice.

Indexed as

LipopolysaccharidesAcute Lung InjuryAnimalsAnti-Inflammatory AgentsBronchoalveolar Lavage FluidCymenesCytoprotectionDisease Models, AnimalFemaleInflammation MediatorsInterleukin-1betaInterleukin-6LungMiceMice, Inbred BALB CMonoterpenes4-cymeneAnti-Inflammatory AgentsCymenesInflammation MediatorsInterleukin-1betaInterleukin-6interleukin-6, mouseLipopolysaccharidesMonoterpenesPeroxidaseRela protein, mouseSuperoxide DismutaseTranscription Factor RelATumor Necrosis Factor-alpha

Identifiers

PMID24085645
OpenAlexW2008865185

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.